We are live on
!
Find out more
NVPX
Norwest Venture Partners XIII Portfolio holdings
AUM
$25.8M
1-Year Est. Return
76.52%
This Fund
S&P 500
This Quarter
Est. Return
+33.94%
1 Year Est. Return
-76.52%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$119M
AUM Growth
–
Cap. Flow
+$105M
Cap. Flow
% of AUM
87.76%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
1
New
1
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SILK
Silk Road Medical, Inc. Common Stock
SILK
|
+$105M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
N
AEPI
BAS
GX
CVGI
KL
FCMI
KCM
Norwest Venture Partners XIII's Q2 2019 Portfolio in Review
Q2 2019 is the first quarter with a 13F filing on record for Norwest Venture Partners XIII, which disclosed 1 position worth $119M. Its ten largest holdings account for 100% of the portfolio.
Its largest position is Silk Road Medical, Inc. Common Stock: 2,461,974 shares worth $119M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets.
- Norwest Venture Partners XIII's largest Q2 2019 buy was Silk Road Medical, Inc. Common Stock: 2,461,974 shares worth $119M.
- Norwest Venture Partners XIII's ten largest holdings make up 100% of its $119M portfolio in Q2 2019.
- Norwest Venture Partners XIII disclosed 1 position in Q2 2019, its first 13F filing on record.
Based on Norwest Venture Partners XIII's 13F filing for Q2 2019, filed 12 Jul 2019.